Trademarkia Logo

Canada

C$
VELOCIMAB
APPROVED

on 19 Feb 2025

Last Applicant/ Owned by

REGENERON PHARMACEUTICALS, INC.

777 Old Saw Mill River RoadTarrytown, NY 10591

US

Serial Number

2139025 filed on 8th Oct 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

VELOCIMAB

Trademark usage description

genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies.

Classification Information


Class [042]
Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies.


Classification kind code

11

Mark Details


Serial Number

2139025

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 19th Feb 2025
Advertised
Submitted for opposition 27
on 21st Jan 2025
Approval Notice Sent
Submitted for opposition 26
on 21st Jan 2025
Approved
Submitted for opposition 22
on 13th Jan 2025
Search Recorded
Submitted for opposition 287
on 11th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 8th Oct 2021
Filed
Submitted for opposition 1
on 8th Oct 2021
Created
Submitted for opposition 31
on 8th Oct 2021
Formalized